NO20022149L - Ikke-viralt genleveringssystem - Google Patents
Ikke-viralt genleveringssystemInfo
- Publication number
- NO20022149L NO20022149L NO20022149A NO20022149A NO20022149L NO 20022149 L NO20022149 L NO 20022149L NO 20022149 A NO20022149 A NO 20022149A NO 20022149 A NO20022149 A NO 20022149A NO 20022149 L NO20022149 L NO 20022149L
- Authority
- NO
- Norway
- Prior art keywords
- delivery system
- gene delivery
- viral gene
- viral
- gene
- Prior art date
Links
- 238000001476 gene delivery Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20022149A NO317654B1 (no) | 2002-05-03 | 2002-05-03 | Formulering som inneholder en nukleinsyre og et kitosan, fremgangsmate for fremstilling av formuleringen, samt anvendelser derav. |
| PCT/NO2003/000144 WO2003092740A1 (en) | 2002-05-03 | 2003-05-02 | Non-viral gene delivery system |
| AU2003228157A AU2003228157A1 (en) | 2002-05-03 | 2003-05-02 | Non-viral gene delivery system |
| EP03725898A EP1549349A1 (en) | 2002-05-03 | 2003-05-02 | Non-viral gene delivery system |
| CNA038123487A CN1655826A (zh) | 2002-05-03 | 2003-05-02 | 非病毒类基因送递系统 |
| JP2004500923A JP2005538943A (ja) | 2002-05-03 | 2003-05-02 | 非ウイルス性遺伝子送達システム |
| CA002491708A CA2491708A1 (en) | 2002-05-03 | 2003-05-02 | Non-viral gene delivery system |
| US10/513,311 US20050164964A1 (en) | 2002-05-03 | 2003-05-02 | Non-viral gene delivery system |
| US11/848,399 US20080085242A1 (en) | 2002-05-03 | 2007-08-31 | Non-viral gene delivery system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20022149A NO317654B1 (no) | 2002-05-03 | 2002-05-03 | Formulering som inneholder en nukleinsyre og et kitosan, fremgangsmate for fremstilling av formuleringen, samt anvendelser derav. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20022149D0 NO20022149D0 (no) | 2002-05-03 |
| NO20022149L true NO20022149L (no) | 2003-11-04 |
| NO317654B1 NO317654B1 (no) | 2004-11-29 |
Family
ID=19913596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20022149A NO317654B1 (no) | 2002-05-03 | 2002-05-03 | Formulering som inneholder en nukleinsyre og et kitosan, fremgangsmate for fremstilling av formuleringen, samt anvendelser derav. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20050164964A1 (no) |
| EP (1) | EP1549349A1 (no) |
| JP (1) | JP2005538943A (no) |
| CN (1) | CN1655826A (no) |
| AU (1) | AU2003228157A1 (no) |
| CA (1) | CA2491708A1 (no) |
| NO (1) | NO317654B1 (no) |
| WO (1) | WO2003092740A1 (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040016013A1 (en) * | 2002-07-18 | 2004-01-22 | Gonzalo Hortelano | Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| KR20070057932A (ko) * | 2004-09-15 | 2007-06-07 | 오츠카 세이야쿠 가부시키가이샤 | 경점막용 조성물, 및 경점막 흡수의 향상 방법 |
| KR100718077B1 (ko) * | 2005-09-12 | 2007-05-14 | 재단법인서울대학교산학협력재단 | 만노스화 키토산 유도체 및 이를 이용한 유전자 전달체 |
| CN102164618A (zh) * | 2006-03-30 | 2011-08-24 | 恩根尼公司 | 用于体内转染肠细胞的非病毒组合物和方法 |
| CN100577688C (zh) * | 2006-04-19 | 2010-01-06 | 中国科学院化学研究所 | 超支化壳聚糖或超支化乙二醇壳聚糖及其制备方法 |
| JP2010503640A (ja) * | 2006-09-15 | 2010-02-04 | エフエムシー バイオポリマー エイエス | オリゴヌクレオチド非ウイルスデリバリーシステム |
| KR100825519B1 (ko) * | 2007-01-05 | 2008-04-25 | 주식회사 바이오폴리메드 | 키토산 기재 고분자 접합체 및 그 제조방법 |
| EP3711755A1 (en) | 2007-06-29 | 2020-09-23 | Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. | Method of fixing and expressing physiologically active substance |
| RU2010116775A (ru) * | 2007-09-28 | 2011-11-10 | Энджин, Инк. (Ca) | Высококонцентрированные композиции полиплекса хитозана и нуклеиновой кислоты |
| CA2794923A1 (en) * | 2009-03-31 | 2010-10-07 | Engene, Inc. | Highly acidic chitosan-nucleic acid polyplex compositions |
| CA2820236C (en) | 2012-06-15 | 2022-07-19 | The Royal Institution For The Advancement Of Learning/Mcgill University | Non-viral nanoparticle-based delivery system |
| US20150297714A1 (en) * | 2012-10-29 | 2015-10-22 | The Board Of Trustees Of The University Of Arkansas | Novel mucosal adjuvants and delivery systems |
| CN106978444B (zh) * | 2016-01-15 | 2021-12-17 | 江苏命码生物科技有限公司 | 一种向细胞中导入核酸的方法 |
| EP3538659A4 (en) * | 2016-11-09 | 2020-07-15 | Engene, Inc. | INTESTINAL EXPRESSION OF THE SCHEDULED DEATH LIGAND 1 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6316007B1 (en) * | 1995-04-04 | 2001-11-13 | Wound Healing Of Oklahoma | Combined physical and immunotherapy for cancer |
| US6184037B1 (en) * | 1996-05-17 | 2001-02-06 | Genemedicine, Inc. | Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| JP2000514440A (ja) * | 1996-07-09 | 2000-10-31 | ザ ジョーンズ ホプキンス ユニバーシティー | 遺伝子輸送システム |
| GB9713980D0 (en) * | 1997-07-03 | 1997-09-10 | Danbiosyst Uk | New conjugates |
-
2002
- 2002-05-03 NO NO20022149A patent/NO317654B1/no not_active IP Right Cessation
-
2003
- 2003-05-02 WO PCT/NO2003/000144 patent/WO2003092740A1/en not_active Ceased
- 2003-05-02 US US10/513,311 patent/US20050164964A1/en not_active Abandoned
- 2003-05-02 CN CNA038123487A patent/CN1655826A/zh active Pending
- 2003-05-02 JP JP2004500923A patent/JP2005538943A/ja active Pending
- 2003-05-02 EP EP03725898A patent/EP1549349A1/en not_active Withdrawn
- 2003-05-02 AU AU2003228157A patent/AU2003228157A1/en not_active Abandoned
- 2003-05-02 CA CA002491708A patent/CA2491708A1/en not_active Abandoned
-
2007
- 2007-08-31 US US11/848,399 patent/US20080085242A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005538943A (ja) | 2005-12-22 |
| NO20022149D0 (no) | 2002-05-03 |
| US20050164964A1 (en) | 2005-07-28 |
| CA2491708A1 (en) | 2003-11-13 |
| US20080085242A1 (en) | 2008-04-10 |
| NO317654B1 (no) | 2004-11-29 |
| WO2003092740A1 (en) | 2003-11-13 |
| CN1655826A (zh) | 2005-08-17 |
| AU2003228157A1 (en) | 2003-11-17 |
| EP1549349A1 (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1497655A4 (en) | IMPROVED GENE EXPRESSION SYSTEM | |
| DK1545662T3 (da) | Lægemiddelindgivelsessystem | |
| NO20041315L (no) | Medikamentavleveringssystem | |
| DK1481652T3 (da) | Linseafgivelsessystem | |
| DE602004018237D1 (de) | Doppelhülliges Stenteinbringungssystem | |
| NL1022316A1 (nl) | Verbindingssysteem. | |
| ATE405630T1 (de) | Wirkstoffabgabesysteme | |
| EP1793865A4 (en) | GENETIC OR DRUG DELIVERY SYSTEM | |
| BRPI0312769A2 (pt) | sistema de fornecimento de combustível aperfeiçoado | |
| ATE350331T1 (de) | Dosiersystem | |
| PL376169A1 (en) | Drug delivery system | |
| GB0426641D0 (en) | Protein delivery system | |
| NO20022149D0 (no) | Ikke-viralt genleveringssystem | |
| EP1490108A4 (en) | DRAG11 GENERAL FAMILY (DRAGON) | |
| DK1357642T3 (da) | Tilslutningssystem | |
| NL1022551A1 (nl) | Ventilatiestelsel. | |
| NO20022148D0 (no) | Ikke-viralt genleveringssystem | |
| DE60323800D1 (de) | Bogenausleger | |
| GB0324173D0 (en) | Flexible delivery system | |
| AU2003273035A1 (en) | Gene vaccine | |
| NO20052073D0 (no) | ACC-gen. | |
| NO20043613L (no) | Genetisk polymorfi i preprotachykiningenet | |
| DE60220721D1 (de) | Eduktor-mischersystem | |
| AU2003238616A1 (en) | Gene delivery system | |
| DE50301827D1 (de) | Verteilsystem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |